A multi-omics approach to identify the impact of miR-411ed on NSCLC TKI resistance
Daniel del Valle Morales, Giulia Romano, Michela Saviana, Patrick S. Nana-Sinkam, Giovanni Nigita, Mario Acunzo
This study uses a multi-omics approach to show miR-411ed enhances Osimertinib efficacy in TKI-resistant NSCLC by targeting STAT3 and altering interferon and ERK/MAPK pathways.
bioRxiv · Apr 3, 2026 · PreprintCancer Biology